Filing Details

Accession Number:
0001209191-13-006239
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-02-04 19:59:12
Reporting Period:
2013-01-31
Filing Date:
2013-02-04
Accepted Time:
2013-02-04 19:59:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1555280 Zoetis Inc. ZTS Pharmaceutical Preparations (2834) 460696167
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1567807 Stefan Weiskopf C/O Pfizer Inc.,
Five Giralda Farms
Madison NJ 07940
Executive Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2013-02-01 320 $31.14 320 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Stock Option Acquisiton 2013-01-31 21,398 $0.00 21,398 $26.00
Class A Common Stock Restricted Stock Units Acquisiton 2013-01-31 5,769 $0.00 5,769 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
21,398 2016-01-31 2023-01-31 No 4 A Direct
5,769 No 4 A Direct
Footnotes
  1. Grant of stock option (right to buy Zoetis Inc. Class A Common Stock) pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The option vests on the third anniversary of the date of grant.
  2. Grant of restricted stock units pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The units vest on the third anniversary of the date of the grant.
  3. Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. Class A Common Stock.
  4. Not applicable.